BPGbio

Bp Gbio

Biotechnology, 500 Old Path Ste 3, Framingham, Massachusetts, Connecticut, 01701, United States, 11-50 Employees

berghealth.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is BPGBIO

BPGbio is a clinical-stage biopharma reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery for humanity. Our...

Read More

map
  • 500 Old Connecticut Path Ste 3, Framingham, Massachusetts, 01701, United States Headquarters: 500 Old Connecticut Path Ste 3, Framingham, Massachusetts, 01701, United States
  • 2006 Date Founded: 2006
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies
  • Niven Narain CEO:   Niven Narain

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from BPGBIO

BPGbio Org Chart and Mapping

Employees

Greg Miller

Associate Director, AI and Machine Learning

Valerie Bussberg

Senior Research Associate

Wilson Peng

Bioanalytical Senior Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BPGbio

Answer: BPGbio's headquarters are located at 500 Old Path Ste 3, Framingham, Massachusetts, Connecticut, 01701, United States

Answer: BPGbio's phone number is 61********

Answer: BPGbio's official website is https://berghealth.com

Answer: BPGbio's revenue is $10 Million to $25 Million

Answer: BPGbio's SIC: 2834

Answer: BPGbio's NAICS: 325412

Answer: BPGbio has 11-50 employees

Answer: BPGbio is in Biotechnology

Answer: BPGbio contact info: Phone number: 61******** Website: https://berghealth.com

Answer: BPGbio is a clinical-stage biopharma reimagining how patient biology can be modeled using unbiased AI algorithms, to accelerate and de-risk the process of drug discovery for humanity. Our Interrogative Biology platform has produced and guided development of more than a dozen therapeutics and diagnostics candidates in the areas of oncology, neurology and rare diseases, including several in advanced clinical stages. As BPGbio continues to expand our biobank, and the network insights that are derived from it, we anticipate more promising discoveries made with improved time and cost efficiency.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access